All In Biotech

Drug Trial Radar · NCT02726386

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

A Multicenter, International, Open-label, Safety Study of ND0612, a Solution of Levodopa/Carbidopa Delivered Via a Pump System as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease

Last checked: Nov 19, 2026Latest source record: May 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

214

Actual

Start

May 4, 2016

Primary completion

Sep 9, 2019

Study completion Feb 2027

Sponsor

Lead sponsor
NeuroDerm Ltd.Industry
Sponsor type
Industry
First posted
Apr 1, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa (LD/CD) delivered via a pump system as a continuous SC infusion in subjects with advanced Parkinson's Disease (PD).

Conditions

  • Parkinson's Disease

Interventions

  • ND0612Drug

    ND0612, a solution of levodopa/carbidopa (LD/CD) delivered continuously subcutaneously (SC) via an infusion pump system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse Events (Long-term Safety)Time frame: Baseline to Month 12
  2. Percentages of Subjects Who Complete the 12-month Treatment Period or Discontinue Due to AE (Tolerability)Time frame: Baseline to Month 12

Locations

57 sites in 9 countries. Site status is shown where the registry gives one.

  • Xenoscience

    Phoenix, Arizona

  • Clinical Trials Inc.

    Little Rock, Arkansas

  • The Parkinsons and Movement Disorder Institute

    Fountain Valley, California

  • Neuro Pain Medical Center

    Fresno, California

  • University of Colorado Denver

    Aurora, Colorado

  • Rocky Mountain Movement Disorders Center

    Englewood, Colorado

  • Parkinson's Disease and Movement Disorder Center of Boca Raton

    Boca Raton, Florida

  • MD Clinical

    Hallandale, Florida

  • Infinity Clinical Research, LLC

    Hollywood, Florida

  • University of Florida Health at Jacksonville

    Jacksonville, Florida

  • Neurology Associates, PA

    Maitland, Florida

  • Parkinsons Disease Treatment Center of Southwest Florida

    Port Charlotte, Florida

  • Suncoast Neuroscience Associates

    St. Petersburg, Florida

  • Infinity Clinical Research, LLC

    Sunrise, Florida

  • USF Health Parkinson's Disease and Movement Disorders

    Tampa, Florida

  • Northwestern University

    Chicago, Illinois

  • Unity Point Health

    Des Moines, Iowa

  • University of Maryland, Neurology

    Baltimore, Maryland

  • QUEST Research Institute

    Farmington Hills, Michigan

  • Henry Ford Hospital

    West Bloomfield, Michigan

  • Pyramid Clinical Research

    Somerset, New Jersey

  • University of Cincinnati

    Cincinnati, Ohio

  • The Movement Disorder Clinic of Oklahoma

    Tulsa, Oklahoma

  • Synergy Trials

    Richmond, Virginia

  • Sentara Neuroscience Institute

    Virginia Beach, Virginia

  • Premier Research

    Spokane, Washington

  • Medical University Innsbruck

    Innsbruck, Austria

  • NEUROHK, s.r.o.

    Choceň, Czechia

  • Clintrial s.r.o.

    Prague, Czechia

  • Vestra Clinics, s.r.o.

    Rychnov nad Kněžnou, Czechia

  • Centre Hospitalier d'Aix

    Aix-en-Provence, France

  • CHU d'Amiens, Hopital Sud

    Amiens, France

  • Hopital Neurologique Pierre Wertheimer

    Bron, France

  • Hôpital Gabriel Montpied

    Clermont-Ferrand, France

  • Hopital Roger Salengro

    Lille, France

  • Hopital de la Timone

    Marseille, France

  • CHU de Poitiers

    Poitiers, France

  • Kliniken Beelitz GmbH

    Beelitz-Heilstätten, Germany

  • St. Josefs Hospital

    Bochum, Germany

  • Klinikum-Bremerhaven Reinkenheide

    Bremerhaven, Germany

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.